Home / Science / Longevity Drug May Hinder Exercise Benefits
Longevity Drug May Hinder Exercise Benefits
29 Apr
Summary
- Longevity drug rapamycin may reduce exercise health benefits.
- Rapamycin is FDA-approved for organ transplant rejection.
- Animal studies suggest rapamycin increases lifespan.
A drug commonly used by individuals seeking to enhance their longevity may inadvertently diminish the health advantages gained from physical activity. Rapamycin, which is FDA-approved for preventing organ transplant rejection, has shown potential in increasing lifespans in various animal studies. This has led to its off-label use by some as a longevity aid.
However, recent research indicates that this popular drug might blunt some of the beneficial effects of exercise. Thousands of Americans are reportedly taking rapamycin, making these findings particularly relevant to those who engage in regular physical activity while also pursuing a longer life.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
